Compounds > 7-hydroxy-2-n,n-dipropylaminotetralin

7-hydroxy-2-n,n-dipropylaminotetralin and oxidopamine

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with oxidopamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misu, Y; Okumura, F; Sato, K; Ueda, H2
Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P1

Other Studies

3 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and oxidopamine

ArticleYear
6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats.
    Brain research, 1994, Aug-29, Volume: 655, Issue:1-2

    Topics: Acetylcholine; Animals; Apomorphine; Corpus Striatum; Dopamine Agonists; Male; Medial Forebrain Bundle; Microdialysis; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Tetrahydronaphthalenes

1994
L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats.
    Brain research, 1995, Nov-06, Volume: 698, Issue:1-2

    Topics: Acetylcholine; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Drug Synergism; Ergolines; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Quinpirole; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes

1995
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
    The European journal of neuroscience, 2000, Volume: 12, Issue:6

    Topics: Animals; Antiparkinson Agents; Benzazepines; Binding, Competitive; Corpus Striatum; Denervation; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Enkephalins; Excitatory Amino Acid Antagonists; Gene Expression; Levodopa; Male; Neural Pathways; Neurons; Opioid Peptides; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substantia Nigra; Sympatholytics; Tachykinins; Tetrahydronaphthalenes; Tritium; Ventral Tegmental Area

2000